Exchange Traded Concepts LLC Lowers Holdings in Masimo Co. (NASDAQ:MASI)

Exchange Traded Concepts LLC lowered its stake in Masimo Co. (NASDAQ:MASI - Free Report) by 15.9% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 10,552 shares of the medical equipment provider's stock after selling 1,998 shares during the quarter. Exchange Traded Concepts LLC's holdings in Masimo were worth $1,744,000 as of its most recent filing with the SEC.

A number of other large investors also recently added to or reduced their stakes in MASI. NBC Securities Inc. boosted its stake in shares of Masimo by 47.1% in the third quarter. NBC Securities Inc. now owns 228 shares of the medical equipment provider's stock worth $30,000 after acquiring an additional 73 shares during the last quarter. UMB Bank n.a. boosted its stake in Masimo by 180.9% during the 4th quarter. UMB Bank n.a. now owns 191 shares of the medical equipment provider's stock worth $32,000 after purchasing an additional 123 shares during the last quarter. Trust Co. of Vermont purchased a new stake in shares of Masimo during the fourth quarter worth $33,000. Northwestern Mutual Wealth Management Co. raised its position in shares of Masimo by 133.3% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 350 shares of the medical equipment provider's stock valued at $44,000 after buying an additional 200 shares during the last quarter. Finally, GAMMA Investing LLC lifted its stake in shares of Masimo by 136.5% in the fourth quarter. GAMMA Investing LLC now owns 466 shares of the medical equipment provider's stock worth $77,000 after buying an additional 269 shares in the last quarter. 85.96% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of analysts have commented on MASI shares. BTIG Research increased their price objective on shares of Masimo from $166.00 to $170.00 and gave the company a "buy" rating in a report on Monday, October 14th. Wells Fargo & Company increased their price target on Masimo from $171.00 to $193.00 and gave the company an "overweight" rating in a report on Wednesday, December 11th. Stifel Nicolaus restated a "buy" rating and issued a $190.00 target price (up from $170.00) on shares of Masimo in a report on Friday, November 22nd. Needham & Company LLC reiterated a "hold" rating on shares of Masimo in a report on Wednesday, January 22nd. Finally, Piper Sandler boosted their price target on shares of Masimo from $180.00 to $210.00 and gave the company an "overweight" rating in a research report on Wednesday, December 18th. Three equities research analysts have rated the stock with a hold rating and five have given a buy rating to the stock. According to MarketBeat.com, Masimo presently has a consensus rating of "Moderate Buy" and a consensus price target of $179.67.

Masimo Trading Up 0.2 %

Shares of NASDAQ MASI traded up $0.30 during mid-day trading on Monday, reaching $170.54. 437,317 shares of the company's stock were exchanged, compared to its average volume of 518,726. The firm has a market capitalization of $9.13 billion, a price-to-earnings ratio of 117.61 and a beta of 1.01. Masimo Co. has a 52-week low of $101.61 and a 52-week high of $180.97. The company's 50-day moving average is $170.32 and its 200-day moving average is $142.65. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.11 and a current ratio of 2.01.

Masimo (NASDAQ:MASI - Get Free Report) last announced its quarterly earnings results on Tuesday, November 5th. The medical equipment provider reported $0.98 earnings per share for the quarter, beating analysts' consensus estimates of $0.84 by $0.14. Masimo had a net margin of 3.85% and a return on equity of 14.98%. The business had revenue of $504.60 million during the quarter, compared to analysts' expectations of $502.87 million. During the same period last year, the business earned $0.63 earnings per share. The business's revenue for the quarter was up 5.4% on a year-over-year basis. Analysts expect that Masimo Co. will post 4.1 EPS for the current fiscal year.

Masimo Company Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.